Tina’s Wish Grants support early-career researchers and collaborative teams developing ovarian cancer screens, prevention strategies, and clinically ready biomarkers to advance early detection and prevention.
A2C’s full proposal deadline moved from December 15, 2026 to January 4, 2027, and invitations moved from October 26 to November 6, 2026. The LOI cycle is explicitly closed, full applications remain invitation-only, and award notification moved from April 5 to May 3, 2027; other schedule details also changed.
Acceleration to Clinic Grant supports investigator teams with research funding and expert advice to validate ovarian cancer biomarkers and advance early detection approaches toward clinical use.
Amy Krouse Rosenthal Foundation Research Grant for Early Detection of Ovarian Cancer supports researchers studying premalignant lesions and biomarkers to detect ovarian cancer and its recurrence.
AstraZeneca Early Career Ovarian Cancer Research Grant supports fellows and early career faculty conducting innovative ovarian cancer research to generate preliminary data and build research independence.
Accelerator Awards support investigators pursuing ambitious four-year neuroendocrine cancer research to advance early detection, develop new therapies, and match treatments to individual tumor biology.
Early Career Investigator Grant supports junior faculty researching ovarian and related gynecologic cancers, giving them time to develop independent work with the depth to pursue further funding.